author-photo

Marion Blank

Janssen Pharmaceutica

49

Papers

5984

Citations

Citation Trend

Filter By

Papers (39) Sort By

Journal Conference Others

Comparisons of Serum Infliximab and Antibodies-to-Infliximab Tests Used in Inflammatory Bowel Disease Clinical Trials of Remicade®.

2017 Aaps Journal
Show All
- Source
- Cite
- Save
Citations (36)
O-001 A Multicenter, Double-Blind, Placebo-Controlled Phase3 Study of Ustekinumab, a Human IL-12/23P40 mAB, in Moderate-Service Crohn's Disease Refractory to Anti-TFNα: UNITI-1

2016 Inflammatory Bowel Diseases
Show All
- Source
- Cite
- Save
Citations (40)
Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection

2016 Gastroenterology
Show All
- Source
- Cite
- Save
Citations (159)
OC-005 A Multicenter, Double-Blind, Placebo (PBO)-Controlled Ph3 Study of Ustekinumab (UST), A Human IL-12/23P40 MAB, in Moderate-Severe Crohn’s Disease (CD) Refractory to anti-TNFΑ: UNITI-1

2016 Gut
Show All
- Source
- Cite
- Save
Citations (3)
Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease

2016 The New England Journal of Medicine
Show All
- Source
- Cite
- Save
Citations (306)
Comparison of Commercially Available Assays for Infliximab Concentrations and Antibodies to Infliximab With Assays Developed at Janssen and Used in Clinical Studies of Remicade (R) : Iinfliximab in IBD Patients

2015 The American Journal of Gastroenterology
Show All
- Source
- Cite
- Save
Citations (0)
Comparison of Commercially Available Assays for Infliximab Concentrations and Antibodies to Infliximab With Assays Developed at Janssen and Used in Clinical Studies of Remicade®: Iinfliximab in IBD Patients Presidential Poster: 1853

2015 The American Journal of Gastroenterology
Show All
- Source
- Cite
- Save
Citations (0)
749 Infliximab for Prevention of Recurrence of Post-Surgical Crohn's Disease Following Ileocolonic Resection: A Randomized, Placebo-Controlled Study

2015 Gastroenterology
Show All
- Source
- Cite
- Save
Citations (8)
Endoscopic and Clinical Variables That Predict Sustained Remission in Children With Ulcerative Colitis Treated With Infliximab

2013 Clinical Gastroenterology and Hepatology
Show All
- Source
- Cite
- Save
Citations (45)
Pharmacokinetics of infliximab in children with moderate-to-severe ulcerative colitis: results from a randomized, multicenter, open-label, phase 3 study.

2013 Inflammatory Bowel Diseases
Show All
- Source
- Cite
- Save
Citations (54)